Pharmacopsychiatry 1992; 25(3): 126-135
DOI: 10.1055/s-2007-1014393
© Georg Thieme Verlag KG Stuttgart · New York

Proof of Efficacy of Nootropics for the Indication "Dementia" (Phase III) - Recommendations*

K.  Menges
  • Bundesgesundheitsamt
    Institut für Arzneimittel
    Seestraße 10
    D-1000 Berlin 65
* Joint paper of the Advisory Committees to the German Federal Health Office in matters of approval and review of existing medicines - Committee A "New Substances" and Committee B 3 "Neurology and Psychiatry" - represented by the following members: Prof. Dr. O. Benkert, Mainz; Prof. Dr. H. Coper, Berlin;Dipl.-Math. U. Ferner, Basel; Prof. dr. Dr. J. M. Fox, Köln; Prof. Dr. M. Gastpar, Essen; Prof. Dr. H. Herrschaft, Lüneburg; Prof. Dr. F. Hoffmeister, Wuppertal; Prof. Dr. W. Janke, Würzburg; Prof. Dr. S. Kanowski, Berlin; Prof. Dr. H. J. Möller, Bonn; Prof. Dr. Dr. P. Netter, Gießen; Editorial Assistant: Dr. K. Menges.
Further Information

Publication History

Publication Date:
13 March 2008 (online)